… also affected the sodium and calcium channel activities of … by the Food and Drug
Administration in 2003, is used to treat … , rosuvastatin should be used with active monitoring for QT …

… and sponsors agree should be conducted post-approval with … or labeling suggest monitoring
and dose adjustment as … P-gp, 2 PMRs specified rosuvastatin as a probe substrate for …

… rosuvastatin has better efficacy in improving lipid profile than other molecules of the same
class … The US Food and Drug Administration recommends that rosuvastatin therapy in Asian …

… This review focusses on the impact of genetic variants on the … The United States Food and
Drug Administration (FDA) … Paradoxically, the low activity ABCG2 variant was found to be …

… The findings of this study have implications both to help guide safety monitoring with statin
… blood levels for rosuvastatin, atorvastatin, and simvastatin acid, suggesting a class effect. …

… Therefore, dose adjustment or monitoring may be … The FDA approved SARS-CoV-2 antivirals
available on the market … between ensitrelvir and midazolam, rosuvastatin, and digoxin has …

… while on a combination of ribociclib and rosuvastatin therapy. She had been taking both …
This is the first case in which the combination of ribociclib and rosuvastatin has been shown …

… and post-approval study requirements for recent FDA-approved … reviews (DURs) and
adverse drug reaction monitoring. … , which resulted in rosuvastatin product labeling changes for …

… Historically, the FDA has focused its use of RWD on safety … that is already approved or to
support or satisfy post-approval study … an opportunity for machine learning/artificial intelligent …

… US Food and Drug Administration (FDA)-approved indication … profile consistent with that of
the GLP-1RA class [65]. Based on … that require clinical monitoring, such as levothyroxine [24, …